Contact Us

TRANSPORTATION NEWS

Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer

May 30, 2024

SHANGHAI and WARREN,N.J.,May 23,2024--Laekna,Inc. (2105.HK),a science-driven,clinical-stage biotechnology company,announced thatthe company has received approval from the U.S. Food and Drugs Administr

Infobird Co., Ltd Receives Notification from Nasdaq for Failure to Timely File Form 20-F

May 30, 2024

HONG KONG,May 24,2024-- Infobird Co.,Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"),a software-as-a-service provider of AI-powered customer engagement solutions in China,today re

ZERO LATENCY ANNOUNCES THE RELEASE DATE FOR WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX, COMING OCTOBER 2024

May 30, 2024

Set in the Warhammer 40,000: Space Marine universe,the exclusive new free-roam VR experience will be available at Zero Latency\'s 90+ venues globally.

The 6th WCIFIT Attracts Global Leaders and Fortune 500 Companies

May 30, 2024

CHONGQING,China,May 23,2024-- A news report from iChongqing- On May 23,the 6th Western China International Fair for Investment and Trade (WCIFIT) officially opened in Chongqing.

Emeren Announces First Quarter 2024 Financial Results

May 30, 2024

STAMFORD,Conn.,May 24,2024--Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL),a leading global solar project developer,owner,and operator,today announced i

Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024

May 30, 2024

SUZHOU,China,May 23,2024-- On May 10,2024,Cure Genetics announced the safety and efficacy data of their CAR-NKT product,CGC729,for patients with relapsed and refractory metastatic renal cell carcinoma

1 ... 300 301 302 303 304 305 306 ... 314